The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Bellack, A. S.
* Articles by Yang, Y.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Bellack, A. S.
* Articles by Yang, Y.
Related Collections
* Atypical Neuroleptics
* Schizophrenia Spectrum Disorders
* Symptoms/Dimensions
Am J Psychiatry 161:364-367, February 2004
© 2004 American Psychiatric Association


Brief Report

Do Clozapine and Risperidone Affect Social Competence and Problem Solving?

Alan S. Bellack, Ph.D., Nina R. Schooler, Ph.D., Stephen R. Marder, M.D., John M. Kane, M.D., Clayton H. Brown, Ph.D., and Ye Yang, M.S.

OBJECTIVE: The purpose of this investigation was to evaluate the effects of clozapine and risperidone on social skill and problem solving in patients with schizophrenia. METHOD: The Wisconsin Card Sorting Test and the Maryland Assessment of Social Competence were administered at baseline, week 17, and week 29 of a multisite clinical trial. RESULTS: Despite evidence of clinical improvement with both medications, there was virtually no medication effect on either social competence or problem solving. CONCLUSIONS: These findings underscore the circumscribed nature of symptomatic improvement in the broader spectrum of clinical outcomes and suggest that new-generation medications may not be expected to produce substantial changes in social role functioning or social problem-solving capacity in the community. The generalizability of the findings should be viewed cautiously because of the low power of this trial, and replication is warranted.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
P. D. Harvey, T. L. Patterson, L. S. Potter, K. Zhong, and M. Brecher
Improvement in Social Competence With Short-Term Atypical Antipsychotic Treatment: A Randomized, Double-Blind Comparison of Quetiapine Versus Risperidone for Social Competence, Social Cognition, and Neuropsychological Functioning
Am J Psychiatry, November 1, 2006; 163(11): 1918 - 1925.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
S. R. McGurk, C. Carter, R. Goldman, M. F. Green, S. R. Marder, H. Xie, N. R. Schooler, and J. M. Kane
The Effects of Clozapine and Risperidone on Spatial Working Memory in Schizophrenia
Am J Psychiatry, May 1, 2005; 162(5): 1013 - 1016.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org